JUNCTION CITY, Kan., Jan. 9 /PRNewswire/ -- Ventria Bioscience announced today that Angus Connell would be joining the company as Director of Bioprocessing Operations for the company's Junction City facility.
Connell, a Kansas native, has extensive experience in operations, engineering design and process development leadership with Koch Industries and Coffeyville Resources. At Koch Industries, he held positions including Manager of Process Engineering and Director of Engineering and Research. He was most recently the Operations Manager for Coffeyville Resources. Angus received his Bachelor of Science degree in Chemical Engineering from the University of Tulsa.
"Angus brings a wealth of process engineering, operations management, and plant expansion capabilities to our team in Junction City," said Greg Unruh, Vice President and General Manager, Ventria Bioscience. "His experience is vital as we continue with the expansion of our facility. We are continually searching for talented employees with engineering, biology and agronomy experience to fill open positions in our Kansas operations. Many of the candidates we have hired in the last year have been trained by Kansas State University, University of Kansas, McPherson College and other Kansas-based educational institutions. Many are Kansas natives, like Angus, who are looking for the opportunity to become part of the bioscience industry in their home state of Kansas," he said.
"I am quite happy for the opportunity to remain in Kansas, at the same time I get to work in a cutting edge industry where I can continue to learn. My other opportunities would have required me to leave Kansas in order to advance my career," said Connell.
A recent child health study showed that Ventria's Lactiva and Lysomin helped reduce the duration of diarrhea in children by 30 percent when added to rehydration solutions. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization.
For more information, see our website: http://www.ventria.com
Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.
CONTACT: Brandy Sargent, Corporate Communications of Ventria Bioscience,
+1-916-921-6148, ext. 27, BSargent@Ventria.com
Web site: http://www.ventria.com/